Amryt Pharma

This study is for people with a rare condition called partial lipodystrophy, where the body has trouble storing fat properly. It tests the long-term safety and effectiveness of a daily injection called metreleptin. The goal is to see if the drug can help control blood sugar and f…

This study tests a drug called metreleptin in children under 6 years old who have a rare condition called generalized lipodystrophy, where the body loses fat tissue. These children often develop diabetes and very high blood fats. The goal is to see if metreleptin can safely lower…

This study is a registry that collects information from people with generalized or partial lipodystrophy who are already taking the drug metreleptin. The goal is to monitor safety events like pancreatitis, liver problems, and infections over time. No new treatment is being tested…

This study follows about 580 people with a rare skin condition called epidermolysis bullosa (EB) for up to 5 years. Researchers want to see if using Filsuvez gel, which helps heal skin blisters, changes the chance of developing skin cancer. Participants receive standard care, and…